Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study

Messenger RNA (mRNA) vaccination was developed to mitigate the coronavirus disease 2019 pandemic. However, data on antibody kinetics and factors influencing these vaccines’ immunogenicity are limited. We conducted a prospective study on healthy young adults who received two doses of the mRNA-1273 va...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Min Joo, Heo, Jung Yeon, Seo, Yu Bin, Yoon, Young Kyung, Sohn, Jang Wook, Noh, Ji Yun, Cheong, Hee Jin, Kim, Woo Joo, Choi, Ju-yeon, Lee, Young Jae, Lee, Hye Won, Kim, Sung Soon, Kim, Byoungguk, Song, Joon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862064/
https://www.ncbi.nlm.nih.gov/pubmed/36679965
http://dx.doi.org/10.3390/vaccines11010120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862064/
https://www.ncbi.nlm.nih.gov/pubmed/36679965
http://dx.doi.org/10.3390/vaccines11010120

Ejemplares similares